Cargando…

Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point

Detalles Bibliográficos
Autores principales: Graziano, Francesca, Valsecchi, Maria Grazia, Rebora, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158139/
https://www.ncbi.nlm.nih.gov/pubmed/35650558
http://dx.doi.org/10.1186/s12874-022-01627-4
_version_ 1784718775519543296
author Graziano, Francesca
Valsecchi, Maria Grazia
Rebora, Paola
author_facet Graziano, Francesca
Valsecchi, Maria Grazia
Rebora, Paola
author_sort Graziano, Francesca
collection PubMed
description
format Online
Article
Text
id pubmed-9158139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91581392022-06-02 Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point Graziano, Francesca Valsecchi, Maria Grazia Rebora, Paola BMC Med Res Methodol Correction BioMed Central 2022-06-01 /pmc/articles/PMC9158139/ /pubmed/35650558 http://dx.doi.org/10.1186/s12874-022-01627-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Graziano, Francesca
Valsecchi, Maria Grazia
Rebora, Paola
Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
title Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
title_full Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
title_fullStr Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
title_full_unstemmed Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
title_short Correction: Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
title_sort correction: sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158139/
https://www.ncbi.nlm.nih.gov/pubmed/35650558
http://dx.doi.org/10.1186/s12874-022-01627-4
work_keys_str_mv AT grazianofrancesca correctionsamplingstrategiestoevaluatetheprognosticvalueofanewbiomarkeronatimetoeventendpoint
AT valsecchimariagrazia correctionsamplingstrategiestoevaluatetheprognosticvalueofanewbiomarkeronatimetoeventendpoint
AT reborapaola correctionsamplingstrategiestoevaluatetheprognosticvalueofanewbiomarkeronatimetoeventendpoint